Focus forward on R&D Third Quarter (1 July 2015 – 30 Sept. 2015) · Net revenues were SEK 0 (7,152,000) and other operating income was SEK 74,000 (2,000). · Loss before tax was SEK 53,948,000 (3,761,000). (For further information see page 6.) · Impaired value for the CIRCUS-study was SEK 28,135,000 (0) · Earnings per share* were SEK -1.75 (-0.18). · Diluted earnings per share** were SEK -1.75 (-0.18). Nine Months (1 Jan. 2015 – 30 Sept. 2015) · Net revenues were SEK 2,502,000 (7,152,000) and other operating income was SEK 499,000 (1,173,000). · Loss before tax was SEK 83,435,000 (-27,328,000). (For further information see page 6.) · Impaired value for the CIRCUS-study was SEK28,135,000 (0) · Earnings per share* were SEK -2.78 (-1,07). · Diluted earnings per share** were SEK -2.78 (-1,07). * Profit/loss for the period divided by the average number of shares before dilution at the end of the period. **Profit/loss for the period divided by the average number of shares after dilution at the end of the period. Business highlights in the third quarter of 2015 · NeuroVive refocused CicloMulsion development and discontinued acute myocardial infarction indication. This decision follows the data from the investigator-initiated Phase III CIRCUS study of CicloMulsion® in patients with a specific type of heart attack known as ST-segment elevation myocardial infarction (STEMI) showed that CicloMulsion® had no therapeutic effect on AMI patients undergoing PCI (percutaneous coronary intervention). · NeuroVive announced the departure of CEO, Mikael Brönnegård, and Jan Nilsson, COO, will head up the company in the role of interim CEO in the period until a new CEO is appointed by the Board of Directors. The recruitment process to find a successor has begun. Events post balance sheet · NeuroVive aims to find path forward in antiviral development following discontinuation of OCB-030 preclinical program by Arbutus, formerly OnCore Biopharma, who have decided to discontinue development of OCB-030 (NVP018) so the company can focus its resources on other agents that directly target HBV. NeuroVive believes that the compound still has future potential based on the independent evidence that supports its application in this area. NeuroVive Pharmaceutical AB (publ) is obligated to publish the information contained in this press release in accordance with the Swedish Securities Market Act. This information was provided to the media for publication at 8:30 CEST on November 18, 2015. NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, is listed on NASDAQ OMX Stockholm, Small Cap, under the ticker symbol NVP. The share is also traded on the OTC market in the US, under the ticker symbol NEVPF
NeuroVive: Interim Report 1 Jan. 2015 to 30 Sep. 2015 Focus
Top 10 Most Recent News Articles
Chianti Classico Showcases 2027 Vintages in Florence
A Grand Reunion of the Black Rooster You're not just sipping wine at a garden party—you're diving into a historic event. Come March 1-2, 2027, Florence will again host the much-anticipated Chianti Classico Collection, uniting over 200 eager producers under the iconic vaults of Stazione Leopolda. This isn't just another stop on the wine circuit; it's a pilgrimage to the...
Continue Reading
BETR Faces Securities Fraud Actions Post-Misleading Statements
Unpacking the Legal Drama Around BETR The tale of Better Home & Finance Holding Company (BETR) is like a roadside crash you can't help but stare at. We're talking big, ugly losses and a chance for investors who got roughed up to throw some punches back with a securities fraud class action. The legal honchos at Howard G. Smith's law office are rallying the troops. If...
Continue Reading
Kexing Biopharm Expands Global Reach at CPHI Milan
Kexing Biopharm's Showstopper Moment in Milan Call it a strategic blowout or just audacious timing—Kexing Biopharm's move at the CPHI Milan 2026 has painted a clear picture. From October 6th to 8th, Milan was the stage where Kexing rolled out its showcase, bragging about a pipeline that screams innovation and possibility. And let’s be honest, their timing couldn’t...
Continue Reading
Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO
Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...
Continue Reading
CenterPoint Deploys Crews for Hurricane Aid Relief
CenterPoint’s Commitment Amidst Crisis Now, when a hurricane slams into the coast, it’s go time for everyone in the game. CenterPoint Energy, never one to sit on the sidelines, is showing up with a hefty squad to help fix the mess left by Hurricane Isaias. A robust 355-strong team is heading out to assist with power restoration down there in Florida. This isn’t just...
Continue Reading
ODL’s Impact Door System Wins 2026 Editors' Pick
Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...
Continue Reading
India's Women Apparel Market Grows Amid Innovation
India's Women Apparel Market on the Rise The winds of fashion change are sweeping through India, and the women's apparel market is at the heart of this sartorial hurricane. Set to explode from USD 28,786.82 million in 2024 to USD 45,491.96 million by 2032, this market is turning heads with a compound annual growth rate (CAGR) of 5.21%. What's stirring this pot, you ask?...
Continue Reading
Zoomlion Boosts Mining Gear Amid Global Revenue Surge
An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...
Continue Reading
Duke Energy Braces for Isaias: Key Prep Steps Ahead
Brace Yourself: Duke Energy Gears Up for Isaias In the ever-unpredictable game of Mother Nature versus infrastructure, Duke Energy is stepping into the ring once more, readying to tackle potential outages across the Carolinas as Hurricane Isaias edges near. Listen, if there's one thing I've learned over years of watching these weather events unfold on the stock ticker and...
Continue Reading
Korea Tourism’s Quiz Offers Free Trip Sweepstakes
A Shot at Adventure Without Opening Your Wallet Let me tell you, Korea's got a way of sweeping folks off their feet with a little something for everyone—from a foodie’s paradise to history buff heaven. The Korea Tourism Organization's (KTO) New York Office is lighting up the stage with a slick offer: enter a quiz on their website and you might just be jetting off to...
Continue ReadingTop 5 Most Recently Viewed Articles
Dovre Group Shares Insights on Recent NYAB AB Sale Developments
Dovre Group Provides Insights on Recent Sale to NYAB AB Dovre Group, a prominent player in renewable energy project development, recently reached a significant milestone by completing the sale of its Project Personnel and Norwegian Consulting businesses to NYAB AB. This strategic decision reflects Dovre Group's commitment to enhancing its portfolio and focusing on core...
Continue Reading
Growing Demand in Preclinical Imaging Market through 2029
Growth Projections for the Preclinical Imaging Market The global preclinical imaging market is poised for significant growth, with projections estimating a rise to USD 5.101 million in the coming years. The current market value stands at approximately USD 3.807 million in 2023 and is anticipated to rise steadily to USD 3.997 million in a year. This trajectory showcases a...
Continue Reading
Discover the Ultimate Spring Break Destinations for 2026
Spring Break 2026: A New Era of Adventure Awaits As Spring Break 2026 approaches, students are gearing up for one of the most anticipated times of the year. STS Travel stands at the forefront, offering amazing packages to the hottest destinations including Cancun, Nassau, Punta Cana, and Cabo. These trips are crafted with college students in mind, ensuring unforgettable...
Continue Reading
Aethon United's Major Tender Offer Insights for Investors
Aethon United BR LP, or simply Aethon United, is shaking things up with a fresh cash tender offer targeting its outstanding senior notes due in 2026. This play is all about tightening up their financial game, looking to boost operational agility and bolster overall fiscal health. Let’s break down what this means for noteholders and the company’s larger strategy....
Continue Reading
Unlocking the Future: Duolingo's Rise in Language Learning
Duolingo, Inc. (NASDAQ:DUOL) made waves in the edtech sector with its innovative language learning platform. The surge in demand for language education has put Duolingo under the microscope, and many traders are eyeing how this company plans to sustain its momentum amidst technological evolution. Market Leadership: Duolingo’s Dominance and Diversification As a...
Continue Reading